These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366 [TBL] [Abstract][Full Text] [Related]
7. EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Sodhi K; Puri N; Inoue K; Falck JR; Schwartzman ML; Abraham NG Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):133-42. PubMed ID: 22209722 [TBL] [Abstract][Full Text] [Related]
8. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. Sodhi K; Inoue K; Gotlinger KH; Canestraro M; Vanella L; Kim DH; Manthati VL; Koduru SR; Falck JR; Schwartzman ML; Abraham NG J Pharmacol Exp Ther; 2009 Dec; 331(3):906-16. PubMed ID: 19717790 [TBL] [Abstract][Full Text] [Related]
9. PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid. Singh SP; Schragenheim J; Cao J; Falck JR; Abraham NG; Bellner L Prostaglandins Other Lipid Mediat; 2016 Sep; 125():8-18. PubMed ID: 27418542 [TBL] [Abstract][Full Text] [Related]
10. Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice. Ma B; Xiong X; Chen C; Li H; Xu X; Li X; Li R; Chen G; Dackor RT; Zeldin DC; Wang DW Endocrinology; 2013 Aug; 154(8):2843-56. PubMed ID: 23696562 [TBL] [Abstract][Full Text] [Related]
11. Endothelial Dysfunction in Obesity and Therapeutic Targets. Engin A Adv Exp Med Biol; 2024; 1460():489-538. PubMed ID: 39287863 [TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARγ. Kim DH; Vanella L; Inoue K; Burgess A; Gotlinger K; Manthati VL; Koduru SR; Zeldin DC; Falck JR; Schwartzman ML; Abraham NG Stem Cells Dev; 2010 Dec; 19(12):1863-73. PubMed ID: 20412023 [TBL] [Abstract][Full Text] [Related]
13. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548 [TBL] [Abstract][Full Text] [Related]
14. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ. Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363 [TBL] [Abstract][Full Text] [Related]
15. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium. Jia J; Davis CM; Zhang W; Edin ML; Jouihan S; Jia T; Bradbury JA; Graves JP; DeGraff LM; Lee CR; Ronnekleiv O; Wang R; Xu Y; Zeldin DC; Alkayed NJ Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473 [TBL] [Abstract][Full Text] [Related]